安枕汤内服配合穴位中频治疗失眠症62例临床观察

目的 观察安枕汤内服配合穴位中频治疗失眠症的临床疗效.方法 将124例患者随机分为治疗组(62例)和对照组(62 例). 穴位中频主要是根据中医内病外治原理,利用中频机无创穴位刺激以达到针法有创刺激的治疗作用.治疗组采用穴位中频(以心俞、神庭、内关、申脉、照海、三阴交等为主穴)配合中药内服治疗失眠症,对照组单纯中药内服,124 例患者均以国际通用SPIEGEL 睡眠量表检测.结果 治疗组近期总体疗效为93 .55%优于对照组的80.65 %(P＜0.05),并且在改善睡眠质量方面,治疗组亦优于对照组(P＜0.05 ).结论 穴位中频配合中药内服治疗失眠症疗效显著.     

穴位埋线治疗慢性胃炎31例的疗效观察

穴位埋线治疗慢性胃炎３１例的疗效观察徐三文关键词慢性胃炎，穴位埋线，疗效观察慢性胃炎属中医学“胃脘痛”范畴，为临床常见病及多发病之一。目前其治疗方法甚多，但疗程长，远期疗效不稳定，治后易反复发作、而穴位埋线则因见效快，疗效确切，简便实用，且无毒副作用...     

穴位埋线结合药物治疗老年性失眠的疗效

目的 对“肾俞、足三里”穴位埋线结合唑吡坦治疗老年性失眠的临床疗效进行评价.方法 65例患者随机分为对照组(n=32)、观察组(n=33),对照组使用唑吡坦治疗,治疗组加用“肾俞、足三里”穴位埋线治疗.用匹兹堡睡眠质量指数量表(PSQI)评定疗效.结果 治疗30 d后,对照组有效率62.50％,观察组有效率93.94％,差异具有统计学意义(P＜0.05);治疗前后2组PSQI各因子及总分评分比较治疗组在改善睡眠质量、日间功能障碍、药物依赖及总分方面明显优于对照组,差异具有统计学意义(P＜0.05).结论 “肾俞、足三里”穴位埋线结合唑吡坦治疗老年性失眠能够提高临床疗效,能更好改善患者的睡眠质量、日间功能,减少对催眠药物的依赖且无副作用,值得临床推广应用.     

穴位埋线治疗椎动脉型颈椎病疗效观察

目的探讨穴位埋线治疗椎动脉型颈椎病的临床疗效。方法将78例病人随机分为治疗组(39例)和对照组(39例)。治疗组采用C3~C7夹脊穴穴位埋线方法,每10d1次,3次为1个疗程;对照组采用针刺C3~C7夹脊穴、风池等,每日1次,10次为1个疗程。观察两组病人眩晕症状的缓解情况。结果治疗组总有效率为94.87%,对照组为79.49%,两组比较差异有统计学意义(P<0.05)。结论穴位埋线治疗椎动脉型颈椎病眩晕的疗效优于常规夹脊穴为主的针刺方法。     

穴位埋线配合光波浴房治疗中老年单纯性肥胖症60例临床观察

目的观察穴位埋线配合光波浴房疗法对中老年单纯性肥胖症的治疗作用。方法将130例中老年单纯性肥胖症患者分为3组,A组:60例中老年单纯性肥胖症患者接受穴位埋线配合光波浴房方法治疗,穴位埋线每2周1次,光波浴房每周1次,每次30min,温度为50℃,共治疗12周。B组:40例单纯采用穴位埋线方法治疗;C组:30例单纯采用光波浴房治疗。治疗强度和频次同A组。治疗前后分别测量患者体质量、身高、腰围、臀围,计算体质量指数(BMI),同时检测患者体脂含量、血脂四项等指标,治疗结束后评定临床疗效。结果与治疗前比较,3组治疗后的腰围、臀围、BMI、体脂含量均明显降低(P0.05),A、B、C组各自的总有效率分别为85.0%、72.5%和66.7%,3组间有显著性差异(P0.05)。结论穴位埋线配合光波浴房疗法可有效改善中老年肥胖症患者的肥胖状态。     

穴位埋线治疗顽固性面瘫30例

目的观察穴位埋线治疗顽固性面瘫的临床疗效。方法将30例顽固性面瘫病人,应用埋线疗法,每20d埋1次,3次为1个疗程。观察治疗前后疗效。结果治愈17例,好转6例,有效4例,无效3例,总有效率90.0%。结论顽固性面瘫病人采用埋线疗法,有助于面神经功能的恢复,明显提高了治愈率,减少了后遗症的发生。     

穴位注射与中药治疗失眠症50例临床观察

目的观察穴位注射与单纯中药治疗失眠症疗效。方法选择2005年6月至2006年12月沈阳市第五人民医院失眠症门诊患者50例。治疗组(针刺水针组)25例,采用穴位注射治疗,对照组25例,单纯用中药治疗。评定治疗4个疗程后失眠改善情况。结果50例患者中,穴位注射痊愈显效率与中药组比较,差异有统计学意义(P<0.01)。经治疗后随访,穴位注射组复发率明显低于中药组。结论穴位注射组近期和远期疗效优于对照组,穴位注射治疗失眠症疗效确切。     

穴位埋线治疗便秘型肠易激综合征疗效观察

[目的]观察穴位埋线治疗便秘型肠易激综合征（IBS—C）的临床疗效。[方法]将64例患者随机分为2组。治疗组32例,以穴位埋线治疗;对照组32例,以多潘立酮治疗。30d后进行疗效观察。[结果]治疗组总有效率为87．5％,对照组为65．6％,2组比较差异有统计学意义（P〈0．05）,治疗前后2组主症状改善情况比较,差异亦有统计学意义（P〈．05）。[结论]穴位埋线治疗IBS—C有较好的临床疗效。     

穴位埋线治疗功能性消化不良

１９９７０６／１２，我们对临床诊断明确的２１例功能性消化不良（ｆｕｎｃｔｉｏｎａｌｄｙｓｐｅｐｓｉａ，ＦＤ）患者试用穴位埋线治疗，取得满意疗效，现报道如下．１对象和方法１．１对象本组２１例患者，经临床表现、纤维内镜、Ｂ型超声检查均明确诊断为ＦＤ，特...     

Nonpharmacologic therapy for insomnia in the elderly

Nonpharmacologic modalities may be used alone or in combination with pharmacologic therapy for effective treatment of insomnia in the elderly. Nondrug treatments involve behavioral, cognitive, and physiologic interventions. Common methods of cognitive behavior therapy for insomnia include: relaxation, stimulus control, sleep restriction, cognitive interventions or therapy, sleep education and sleep hygiene, light therapy, and chronotherapy. Evidence suggests that nonpharmacologic treatments are effective and well suited for the clinical management of insomnia in the elderly.     

Light therapy for insomnia in older adults

Exposure to bright light suppresses the production of melatonin and contributes to the regulation of the circadian rhythm. Because of environmental and medical conditions, older adults are less likely than younger adults to receive the prolonged, high intensity, daily bright light needed to promote a satisfactory sleep-wake cycle. The best available evidence for bright light therapy is in the management of seasonal affective disorder, which is relatively infrequent in the elderly population. For older adults with chronic insomnia, dementia, and nonseasonal depression, there is no consensus on the optimum treatment protocol for bright light therapy. However, in addition to sleep improvement, bright light therapy may be used to reduce unwanted behavioral and cognitive symptoms associated with dementia and depression in the elderly.     

远程失眠认知行为治疗慢性失眠障碍的疗效研究

目的 比较远程失眠认知行为治疗(CBT-I)与面对面CBT-I对失眠患者睡眠影响的差异,研究远程CBT-I的有效性。方法 招募2019年3月至2023年5月重庆市中医院睡眠门诊收治的108例慢性失眠障碍患者,经剔除后最终纳入74例进行分析,其中远程组38例,面对面组36例。使用失眠严重指数(ISI)、匹兹堡睡眠质量指数(PSQI)评估失眠症状以及睡眠质量,使用广泛性焦虑障碍问卷(GAD-7)和患者健康问卷(PHQ-9)评估患者焦虑和抑郁情绪,使用睡眠信念和态度量表(DBAS-16)评估患者的不合理睡眠认知,使用格拉斯哥睡眠努力量表(GSES)量化患者的睡眠努力。比较两组患者的治疗效果。结果 在干预前和干预后,两组ISI、PSQI、GAD-7、PHQ-9、DBAS-16、GSES评分比较差异均无统计学意义(P>0.05)。干预后,面对面组的各问卷得分均显著低于干预前(P<0.05),远程组除GAD-7外的各问卷得分亦显著低于干预前(P<0.05)。结论 远程CBT-I可有效改善中国失眠患者的夜间及日间症状、睡眠不良信念和行为,是可扩大CBT-I获得性的方法。     

穴位治疗对子宫内膜异位症疗效的网状Meta分析

［摘要］　目的　系统评估穴位治疗对子宫内膜异位症(EMT)的疗效。方法　在PubMed、the Cochrane Library、Embase、中国知网等数据库检索以穴位治疗为代表的不同中医外治法治疗EMT的相关文献,检索时间为各数据库建库至2023年6月1日。最终纳入66篇文献,均为随机对照试验（RCT）研究,包括6种治疗组合：单纯中药治疗,单纯西药治疗,单纯穴位治疗,中药联合穴位治疗,西药联合穴位治疗,西药、中药联合穴位治疗。采用网状Meta分析评估治疗方法对主要结局指标癌抗原125（CA125）、雌二醇（E₂）、促卵泡激素（FSH）、黄体生成素（LH）、前列腺素F_2α(PGF_2α）、视觉模拟量表(VAS)评分的影响。结果　一致性模型分析结果显示,在CA125水平的改善方面,西药联合穴位治疗的效果显著优于单纯中药治疗、单纯西药治疗（P<0.05）,其余治疗组比较差异无统计学意义（P>0.05）。在LH水平的改善方面,西药、中药联合穴位治疗的效果显著优于单纯西药治疗（P<0.05）,其余治疗组比较差异无统计学意义（P>0.05）。在PGF_2α水平的改善方面,西药联合穴位治疗的效果显著优于单纯中药治疗、单纯西药治疗、单纯穴位治疗、中药联合穴位治疗以及西药、中药联合穴位治疗（P<0.05）,中药联合穴位治疗及西药、中药联合穴位治疗的效果显著优于单纯西药治疗（P<0.05）,其余治疗组比较差异无统计学意义（P>0.05）。在E₂、FSH水平及VAS评分的改善方面,各治疗组效果差异无统计学意义（P>0.05）。结论　穴位治疗作为辅助疗法,可有效促进EMT关键指标的改善。     

Effects of schedule exercise therapy on chronic insomnia

Schedule exercise therapy (SET) is a novel nonpharmacological intervention for the treatment of chronic insomnia disorder (CID). The aim of this study was to explore the effects of SET on CID. Methods: One hundred and eighteen CID were recruited and randomized into medication (MED) or medication combined with SET (MSET) groups. Over 12 observational weeks, sleep and mood status were evaluated using the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), Self-rating Depression Scale (SDS), and Self-rating Anxiety Scale (SAS). At the end of the observational period, the rates of clinically effective hypnotic use were calculated. At 12 weeks, the PSQI progressively decreased for all subjects combined (P < .001) as well as ISI (P < .001), ESS (P < .001), SDS (P < .001), and SAS (P < .001). The decreases in PSQI (P < .05), ISI (P < .05), SDS (P < .01), and SAS (P < .05) in the MSET group were significantly larger than those in the MED group, but not the same as those in the ESS group (P > .05). At the trial endpoint, the clinically effective rate was significantly higher (P < .05) and the hypnotic usage rate was lower (P < .05) in the MSET group than in the MED group. SET may be an effective treatment for insomnia in patients with CID.     

软肝化瘀方联合穴位离子导入治疗肝纤维化合并失眠患者的临床疗效

目的:观察软肝化瘀方联合穴位离子导入治疗肝纤维化合并失眠患者的临床疗效。方法:纳入肝纤维化合并失眠患者84例,按随机数字表法分为两组。对照组患者42例,给予西医常规治疗及穴位离子导入治疗;治疗组患者42例,在对照组基础上加用软肝化瘀方治疗,疗程均为4个月。治疗4个月后,观察两组患者疗效、治疗前后肝纤维化Ishak评分、血清肝纤维化指标、免疫功能指标、肝功能指标和匹兹堡睡眠质量指数(PSQI)评分。结果:治疗4个月后,治疗组患者总有效率为89.74%,对照组患者总有效率为76.31%,差异有统计学意义(P<0.05);治疗后两组患者Ishak评分、PSQI评分、血清肝纤维化及肝功能指标较同组治疗前显著下降(P<0.05),且治疗组患者下降更显著(P<0.05),血清免疫功能指标较同组治疗前显著提高(P<0.05),且治疗组患者上升更显著(P<0.05)。结论:软肝化瘀方联合穴位离子导入可降低肝纤维化合并失眠患者肝纤维化Ishak评分和PSQI评分,降低血清肝纤维化指标,改善肝功能,增强人体免疫力,改善睡眠质量,临床疗效显著。     

穴位注射缩宫素预防产后出血的效果观察

［摘要］　目的　观察穴位注射缩宫素预防产后出血的效果。方法　选择2019年2月至2020年10月于贵港市中医医院分娩且存在子宫收缩乏力高危因素的孕妇150例,采用随机数字表法分为观察组和对照组,每组75例。在分娩的第三产程,观察组于合谷穴予缩宫素注射5 U;对照组予肌肉注射缩宫素20 U。比较两组产后出血量、血红蛋白、红细胞计数水平,以及子宫收缩乏力和产后出血发生率。结果　观察组产后2 h、24 h的出血量均少于对照组,差异有统计学意义（P<0.05）。观察组产后24 h的血红蛋白、红细胞计数高于对照组,差异有统计学意义（P<0.05）。观察组子宫收缩乏力和宫缩乏力性产后出血的发生率均低于对照组,差异有统计学意义（12.00% vs 25.33%,5.33% vs 16.00%;P<0.05）。结论　采用合谷穴注射缩宫素可以有效增强产妇产后宫缩力度,可有效预防宫缩乏力性产后出血的发生。     

The efficacy and safety of acupoint catgut embedding for peripheral facial paralysis: A protocol for systematic review and meta analysis

Background:Peripheral facial paralysis (PFP) is a consequence of the peripheral neuronal lesion of the facial nerve. It can be either primary (Bell palsy) or secondary. The incidence of PFP is 11.5 to 40.2 per 100,000 people a year. Nearly 70% of patients with PFP recover completely, but almost 30% of patients leave multiple sequelae which caused impacts on the patient''s quality of life, both physically and psychologically. The conventional treatments of PFP are limited for some person because of side-effects. Previous studies have suggested that using acupoint catgut embedding (ACE) alone or combined with other therapeutic methods is effective for PFP. However, whether ACE is effective for PFP is still unknown. The purpose of this systematic review (SR) and meta-analysis will summarize the present evidence of ACE used as an intervention for PFP.Method/Design:Randomized controlled clinical trials that use ACE for PFP will be searched from four international electronic databases (PubMed, Cochrane Library, EMBASE, and Web of Science) and 4 Chinese electronic databases (China National Knowledge Infrastructure, VIP, Wanfang, and China Biology Medicine) to search for relevant literature. We only include studies that were published from the initiation to May 2021. The primary outcomes include effectiveness rate based on House-Brackmann Facial Nerve Grading System. Secondary outcomes will include Sunnybrook facial nerve grading system, Portmann score, facial nerve conduction velocity, Facial Disability Index Scale, adverse events. Two reviewers will perform study selection, data extraction, data synthesis, and quality assessment independently. Assessment of risk of bias and data synthesis will be conducted by using Review Manager 5.3 software. Grade system will be used to evaluate the quality of evidence.Discussion:This systematic review will help establish clinical evidence regarding the efficacy and safety of acupoint catgut embedding for peripheral facial paralysis.Trial registration number:CRD42021243212 (PROSPERO)